drugset / Trial / NCT06509958
Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA
RandomizedParallel-groupTriple-blindTreatment
Summary
Phase Ⅱ, randomized, double-blind, comparator-controlled study to evaluate the efficacy, safety and pharmacokinetics of single injection adductor canal block with HR18034 for postoperative pain management in total knee arthroplasty compared with ropivacaine.
Timeline
- Start
- 2024-08-20
- Primary completion
- 2024-10-10
- Completion
- 2024-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR18034 | Unknown | — | Other |
| Comparator | Ropivacaine | Other / unclassified | — | — |
Indications
No indication recorded.